Home    eJManager.com Add Your Journal   |    Follow on Twitter   |    Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research



Role of propolis in improving the histological and ultrastructural changes of liver after treatment with tamoxifen

Ahmed Mohamed Ahmed Abd El-Mawla, Husam Eldien Husien Osman.

Cited by (1)

Abstract
ABSTRACT
AIM: Breast cancer remains the most common malignancy in women world wide. Estrogen levels appear to be associated with an increased risk for the development of breast cancer. Tamoxifen (TAM), a non steroidal antiestrogen, is used as a chemotherapeutic and chemopreventive agent for breast cancer. Propolis has been reported to be important antioxidant. This study aims to elucidate the protective effects of propolis on rat liver after treatment with TAM.
METHODS: Three groups of adult female albino rats were used; each containing 10 rats. Group 1 (control): rats were administrated with 0.9% NaCl. Group 2 (experimental): rats were received a diet with 20 mg/kg bw TAM. Group 3 (experimental): rats received a diet containing propolis (50 mg/kg bw) prior to daily TAM 20 mg/kg bw. Paraffin sections were used for histopathological studies.
RESULTS: Histopathological degenerative effects in the form of vacuolar degeneration, fatty changes and hydropic degeneration were noticed in TAM treated rat liver. Karyolysis and karyorrhexis were also seen. Dysplasia and chromatin clumping were observed in scattered hepatocytes. Histopathological and ultrastructural changes were diminished in rats treated with propolis prior to TAM.
CONCLUSION: The present study noticed the protective effect of propolis in improving the histological and ultrastructural changes of liver after treatment with TAM.

Key words: Keywords: Propolis, tamoxifen, antiestrogen, breast cancer, antioxidant, liver.


Full text links

Share this Article




ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
Job Opportunities/Service Offers
eJManager OJMS
eJPort Journal Hosting
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons